A Randomised Single Centre Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral Multiple Ascending Daily Doses of AZD1236 Tablet by a Single-Blind, Placebo-Controlled, and Single Dose Relative Bioavailability of the Oral Suspension and Oral Tablet Formulations by an Open Cross-Over in Healthy Japanese Men.
Phase of Trial: Phase I
Latest Information Update: 01 Jul 2009
At a glance
- Drugs AZD 1236 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions
- 01 Jul 2009 Actual patient number (48) added as reported by ClinicalTrials.gov.
- 01 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Oct 2008 Official Title amended as reported by ClinicalTrials.gov.